Effect of blue light emitting diode therapy on recurrent vulvovaginal candidiasis: A randomized assessor‐blinded controlled trial.
Objective: Vulvovaginal Candidiasis (VVC) is a prevalent genital infection in women of reproductive age and requires effective non‐drug therapies. Therefore, this study aimed to investigate the effect of blue light emitting diode (LED) therapy as an alternative treatment for recurrent VVC due to its...
| Publicado en: | Physiotherapy Research International Vol. 29; no. 4; pp. 1 - 10 |
|---|---|
| Autores principales: | , , , |
| Formato: | research tables/charts randomized controlled trial Journal Article |
| Publicado: |
Wiley-Blackwell
Oct2024
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=180521103&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 180521103 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 13582267 GPG jtl: Physiotherapy Research International issn: 13582267 maglogo: Y pubinfo: dt: Oct2024 vid: 29 iid: 4 pid: 480 pub: Wiley-Blackwell place: Malden, Massachusetts artinfo: ui: 180521103 180521103 180521103 10.1002/pri.2129 180521103 ppf: 1 ppct: 9 formats: fmt: – @attributes: type: T – @attributes: type: C – @attributes: type: P tig: atl: Effect of blue light emitting diode therapy on recurrent vulvovaginal candidiasis: A randomized assessor‐blinded controlled trial. aug: au: Shalaby, Radwa M. El‐Kosery, Soheir M. Soliman, Mahmoud M. Osman, Doaa A. affil: Faculty of Physical Therapy, Cairo University, Giza, Egypt sug: subj: Candidiasis, Vulvovaginal Therapy Blue Light Phototherapy Methods Treatment Outcomes Evaluation Recurrence Antiinfective Agents Alternative Therapies Human Randomized Controlled Trials Random Assignment Female Adult Middle Age Integrative Medicine Academic Medical Centers Colony Count, Microbial Vaginosis, Bacterial Candida Anthropometry Multivariate Analysis of Variance Descriptive Research Parametric Statistics Descriptive Statistics Confidence Intervals Treatment Outcomes Questionnaires Adult: 19-44 years Middle Aged: 45-64 years Female ab: Objective: Vulvovaginal Candidiasis (VVC) is a prevalent genital infection in women of reproductive age and requires effective non‐drug therapies. Therefore, this study aimed to investigate the effect of blue light emitting diode (LED) therapy as an alternative treatment for recurrent VVC due to its proven antimicrobial properties. The safety and non‐invasiveness of LED therapy make it a promising option for sensitive tissue applications. Materials and Methods: This randomized controlled trial recruited 60 women with culture‐confirmed VVC. Participants were randomly allocated to two groups. Group A (control group) received standard antifungal treatment with Gynoconazol 0.8% vaginal cream for three consecutive nights (n = 30). Group B (study group) received the same antifungal treatment plus two 60‐min sessions of blue LED therapy directed at the vagina and vulva, with the sessions separated by two days (n = 30). Candida count (via CHROMagar™ Candida) and vaginal pH (via AD110‐AD111 m) were assessed at baseline and one week after initiating treatment. Results: Post‐treatment, group (B) demonstrated a significantly greater reduction in Candida count compared to group (A) (mean difference (MD) 8.267; 95% Confidence Interval (CI) 6.723–9.811; p = 0.0001). However, there was no statistically significant difference in vaginal pH between the groups (MD −0.03; 95% CI −0.244–0.178; p = 0.749). Conclusion: Blue LED therapy effectively reduces Candida count in women with recurrent VVC without adversely affecting the vaginal pH, highlighting its safety and efficacy as a treatment modality. pubtype: Academic Journal doctype: research tables/charts randomized controlled trial Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|